ADULT CONGENITAL HEART DISEASE
Clinical trials for ADULT CONGENITAL HEART DISEASE explained in plain language.
Never miss a new study
Get alerted when new ADULT CONGENITAL HEART DISEASE trials appear
Sign up with your email to follow new studies for ADULT CONGENITAL HEART DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common diabetes drug help adults born with heart defects?
Disease control Recruiting nowThis study tests whether Empagliflozin (Jardiance), a drug already used for heart failure, can help adults born with heart defects. About 40 participants will take the drug and be monitored for changes in heart function, exercise ability, and hospitalizations. The goal is to see …
Matched conditions: ADULT CONGENITAL HEART DISEASE
Phase: PHASE4 • Sponsor: Anita Saraf • Aim: Disease control
Last updated May 17, 2026 06:49 UTC
-
Massive heart biobank launches to unlock secrets of adult heart disease
Knowledge-focused Recruiting nowThis study is creating a large collection of blood samples and health information from 5,000 adults with congenital heart disease and related conditions. Researchers will use this data to better understand how these diseases work and what affects patient health over time. No trea…
Matched conditions: ADULT CONGENITAL HEART DISEASE
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated May 17, 2026 07:06 UTC
-
Heart defects and hidden trauma: 1,000 adults studied for PTSD risk
Knowledge-focused Recruiting nowThis study looks at how living with congenital heart disease from birth may increase the risk of post-traumatic stress disorder (PTSD). Researchers will survey 1,000 adults and interview some to find out which experiences—like past surgeries or bullying—are linked to PTSD. They a…
Matched conditions: ADULT CONGENITAL HEART DISEASE
Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Knowledge-focused
Last updated May 12, 2026 13:40 UTC
-
New registry tracks heart drug use in adults born with heart defects
Knowledge-focused Recruiting nowThis study is a global registry that will collect information from 400 adults with congenital heart disease who are taking a type of diabetes drug called SGLT2 inhibitors. The goal is to understand how these drugs are prescribed, how safe they are, and whether they help with hear…
Matched conditions: ADULT CONGENITAL HEART DISEASE
Sponsor: Leiden University Medical Center • Aim: Knowledge-focused
Last updated May 12, 2026 13:39 UTC